North Charleston's Alcami Corp. recently announced that it has acquired TriPharm Services, a sterile fill-finish manufacturing facility in Morrisville, North Carolina.
The acquisition follows Alcami’s $17 million facility expansion announced last month, augmenting Alcami’s existing sterile fill-finish business. TriPharm’s new manufacturing facility is projected to be operational by the second half of this year.
Madison Dearborn Partners, Alcami’s majority owner, has made an additional investment to fund Alcami’s growth plan. Ampersand Capital Partners, former majority owner of TriPharm, converted a portion of its TriPharm ownership interest into an ownership interest in Alcami.
“Our combination with TriPharm is an important next step in the execution of Alcami’s strategy to focus investments across our network to better serve rapidly growing specialized market segments,” Alcami Interim CEO George Van Kula said in a press release. “TriPharm expands our existing capabilities and provides additional equipment lines that will allow us to better serve the fast-developing biologics market segment.”